维普期刊资源整合服务平台（V6.5）

98篇 您的检索式：作者名="DIRIX L"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in pa- tients with human epidermal growth factor receptor 2-positive meta- static breast cancer显示文摘	Hurvitz SA Dirix L Kocsis J	2013	J Clin Oncol2013，31，9：	1
2	PhaseⅢstudy comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women:The european organisation for research and treatment of cancer breast cancer cooperative group显示文摘	Paridaens R J Dirix L Y Beex L V	2008	J Clin Oncol2008，26，30：	1
3	Phase Ⅲ study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer显示文摘	MILES D W CHAN A DIRIX L Y	2010	J Clin Oncol2010，28，20：	1
4	A phase Ⅰ study of capecitabine in combination with oral leucovorin in patients with intractable solid tumours显示文摘	Cassidy J Dirix L Bissett D	1998	Clin Cancer Res1998，4，11：	1
5	Mature results of a randomized phase Ⅱ multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer显示文摘	Paridaens R Dirix L Lohrisch C	2003	Ann Oncol2003，14，9：	1
6	Mature results of a randomized phase II postmenopausal women with metastatic breast cancer 显示文摘	Atalay G Dirix L Lohrisch C	2003	Ann Oncol2003，，9：	1
7	The effect of exemestane on ser-um lipid rofile in postmenopausal women with metastatic breast canc-er:a companion study to EORTC Trial 10951,'Randomized phaseⅡ study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'显示文摘	Malay G Dirix L Biganzoli L	2004	Ann Oncol2004，15，2：	1
8	Effect of food on the pharmacokinetics of capecitabine and its metabolizes following oral administration in cancer patients显示文摘	Reigner B Verweij J Dirix L	1998	Clin Cancer Res1998，4，4：	1
9	Phase Q randomized study of tras-tuzumab emtansine versus trastuzumab plus docetaxel in patients withhuman epidermal growth factor receptor 2-positive metastatic breastcancer显示文摘	Hurvitz SA Dirix L Kocsis J	2013	J Clin 0ncol2013，31，9：	1
10	Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer 显示文摘	Miles D W Chan A Dirix L Y	2010	J Clin Oncol2010，28，20：	1
11	Nerainib,an irreversible Erb B receptor tyrosine kinase inhibitor,in patients with advanced Erb B2-positive breast cancer显示文摘	Burstein H J Sun Y Dirix L Y	2010	J Clin Oncol2010，28，8：	1
12	Effect offood on the pharmacokinetics of capecitabineand its metabolites following oral administrationin cancer patients显示文摘	REIGNER B VERWEIJ J DIRIX L		Clin Cancer Res'' 1 9980，4，4：	1
13	Coping with toxieities of docetaxel (Taxotere)显示文摘	Schrijvers D Wanders J Dirix L		0，，07：	1
14	First line hormonal treatment(HT) for metastatic breast cancer(MBC) with exemestane(E) or tamoxifen(T) in postmenopausal patients(pts)-A randomized phase Ⅲ trial of the EORTC Breast Group显示文摘	Paridaens R Therasse P Dirix L	2004	Proc Am Soc Clin Oncol2004，，：	1
15	Delivery of adjuvant sequentialdose-dense FEC-Doc to patients with breast cancer is feasible,butdose reductions and toxicity are dependent on treatment sequence显示文摘	Wildiers H Dirix L Neven P	2009	Breast Cancer Res Treat2009，114，1：	1
16	A phaseI study of capecitabine in combination withoral leucovorin in patients with intractablesolid tumors显示文摘	CASSIDY J DIRIX L BISSETT D		Clin Cancer Res0，4，11：	1
17	Mature results of a randomized phase Ⅱ multicenter study of exemestane versus tamoxifeu as first-line hormone therapy for postmeuopausal women with metastatic breast cancer 显示文摘	PARIDAENS R DIRIX L LOHRISCH C	2003	Ann Oncol2003，14，9：	1
18	Coping with toxicities of docetaxel (Taxotere) 显示文摘	Schrijvers D Wanders J Dirix L	1993	Ann Oncol1993，4，7：	1
19	Mature results of a randomized phase Ⅱ multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer显示文摘	Paridaens R Dirix L Lohrisch C	2003	Ann Oncol2003，14，9：	1
20	Angiogene-sis,lymphangiogenesis,growth pattern,and tumor emboli in in-flammatory breast cancer:a review of the current knowledge显示文摘	Vermeulen P B van Golen K L Dirix L Y		0，，：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示